MNKD Earnings

MNKD reported its FY2025Q4 earnings on 2026-02-26, showcasing a revenue of 0.00 against an estimate of 89.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.01 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following MNKD's FY2025Q4 earnings announcement on 2026-02-26, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, MNKD's stock price tends to shift by an average of +2.94% in the 10 days leading up to earnings and +2.16% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate MNKD’s annual revenue to reach 101.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 6.17% and EPS estimates Revise Upward by 14.32% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between MNKD's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 6.17%, while EPS estimates moved Revise Upward by 14.32% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MNKD's stock price typically moves by +2.94% in the 10 days before its earnings and +2.16% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 101.00M.

The earnings call highlights strong financial metrics, optimistic guidance, and strategic growth initiatives. The company expects significant growth in Afrezza sales and FUROSCIX, supported by investments in sales force expansion and new product developments. The strategic financing with Blackstone provides a substantial non-dilutive funding boost. Market opportunities, especially in the NTM market, are promising, and the company is confident in its pricing model. Despite some unclear management responses, the overall sentiment is positive, with potential catalysts like the Afrezza label update and ReadyFlow injector expansion.